| |
|
Controls |
Cases |
Significance |
| Age (Years) |
|
40.1±9.3 |
40.4±8.3 |
P=0.89 |
| Sex |
Male |
16 |
13 |
X2=0.355; df 1; p=0.551 |
| |
Female |
34 |
37 |
| Diagnosis |
Rheumatoid arthritis |
30 |
29 |
|
| |
Systemic Lupus Erythematosis |
13 |
13 |
|
| |
Sjogrens Syndrome |
4 |
6 |
NS |
| |
Systemic Sclerosis |
- |
1 |
|
| |
UCTD/ MCTD |
3 |
1 |
|
| Duration of treatment in yearsMedian (IQR) |
Chloroquine |
- |
3.0 (2.00-5.00) |
|
| |
Hydroxy-chloroquine |
- |
6.0 (5.00-7.00) |
|
| Dosage (mg.kg-1.d-1) |
Chloroquine |
- |
3.7±0.7 |
|
| |
Hydroxy-chloroquine |
- |
5.6±1.1 |
|
|
